Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
|Videos|May 12, 2021
LifeLines: Finding Light
Author(s)Melissa Bernstein
Melissa Bernstein, founder of toy company Melissa & Doug, talks about accepting the self in totality and journeying inwards.
Advertisement
Melissa Bernstein shares insights based on her own experiences from her book,
Melissa Bernstein is the chief creative officer of
Advertisement
Related to this article
Courts cite teen brain science to soften sentences; experts warn generalized neuroscience overreaches and adult responsibility stabilizes by 18 to 20.
Advertisement
Advertisement
Trending on Psychiatric Times
1
September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
2
Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression
3
VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027
4
The Psychiatric Pipeline in Review: Quarter 3, 2026
5